Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation
- 1 September 1995
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 8 (5) , 353-359
- https://doi.org/10.1007/bf00337166
Abstract
Irreversible ductopenic rejection (DR) after orthotopic liver transplantation (OLT) is a major cause of late hepatic allograft failure. A variety of risk factors for DR have been postulated, but they are controversial. All transplant recipients at our institution with graft survival of more than 1 month (n = 120) were examined retrospectively with a view to possible risk factors for DR. These factors included age, sex, underlying liver disease, hepatitis B and C infections, donor-recipient CMV status, post-OLT CMV infections, immunosuppressive regimen, ABO blood type, and HLA class I and class II mismatches. Statistical analysis was performed with the univariate chi-square test or the two-tailed Fischer's exact test. Ten patients (8.3%) developed DR. Seventeen patients had HCV infections after OLT. In this group, the incidence of DR was highest (4 of 17, or 23.5%). This was significantly higher than for all other OLT groups (6 of 103 patients, or 5.8%; P < 0.03). The other factors analyzed did not reach statistical significance, including those that other authors found important for the development of DR. It may well be that hepatitis C infection predisposes one to the development of DR after OLT.Keywords
This publication has 16 references indexed in Scilit:
- Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization.Journal of Clinical Investigation, 1993
- Cytomegalovirus Infection Persists in the Liver Graft in the Vanishing Bile Duct SyndromeHepatology, 1992
- Rejection in Liver TransplantationHepatology, 1989
- Clinical Lessons from PathologyJournal of Clinical Gastroenterology, 1989
- A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factorsHepatology, 1989
- CYTOMEGALOVIRUS INFECTION AND DONOR/RECIPIENT HLA ANTIGENS: INTERDEPENDENT CO-FACTORS IN PATHOGENESIS OF VANISHING BILEDUCT SYNDROME AFTER LIVER TRANSPLANTATIONThe Lancet, 1988
- Pathologic analysis of liver transplantation for primary biliary cirrhosisHepatology, 1988
- INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTSTransplantation, 1988
- EVIDENCE FOR AN IMMUNE RESPONSE TO HLA CLASS I ANTIGENS IN THE VANISHING-BILEDUCT SYNDROME AFTER LIVER TRANSPLANTATIONThe Lancet, 1987
- Functional characterization of infiltrating T lymphocytes in human hepatic allograftsHuman Immunology, 1986